aluates Reports

$ 0.0

Automative

Global Therapeutic Enzyme Drugs Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-35J14141

Global Therapeutic Enzyme Drugs Market Research Report 2023

BUY CHAPTERS

Global Therapeutic Enzyme Drugs Market Research Report 2025

Code: QYRE-Auto-35J14141

Report

July 2025

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Shire Plc

Alexion

Horizon Pharma

Allergan plc

Johnson & Johnson

Recordati Rare Diseases

Pfizer Inc

VIVUS

Digestive Care

BioMarin

Sanofi

Therapeutic Enzyme Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Therapeutic Enzyme Drugs Market

The global market for Therapeutic Enzyme Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Therapeutic Enzyme Drugs are medications that utilize enzymes to treat various medical conditions. These drugs are designed to replace deficient or malfunctioning enzymes in the body or modify biochemical processes. They can target genetic disorders, enzyme deficiencies, and other diseases by restoring normal metabolic pathways. Therapeutic enzyme drugs can be administered through injections or other delivery methods and play a vital role in managing conditions that arise from enzyme dysfunction.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Therapeutic Enzyme Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Enzyme Drugs.

The Therapeutic Enzyme Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Therapeutic Enzyme Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Therapeutic Enzyme Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Therapeutic Enzyme Drugs Market Report

Report Metric	Details
Report Name	Therapeutic Enzyme Drugs Market
CAGR	5%
Segment by Type	Injectable Oral Topical
Segment by Application	Gaucher Disease MPS Disease Gastrointestinal Diseases Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, BioMarin, AbbVie, Shire, Alexion, Horizon Pharma, Allergan, Johnson & Johnson, Recordati Rare Diseases, Pfizer, Vivus, Digestive Care
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Therapeutic Enzyme Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Therapeutic Enzyme Drugs Market report?

Ans: The main players in the Therapeutic Enzyme Drugs Market are Sanofi, BioMarin, AbbVie, Shire, Alexion, Horizon Pharma, Allergan, Johnson & Johnson, Recordati Rare Diseases, Pfizer, Vivus, Digestive Care

What are the Application segmentation covered in the Therapeutic Enzyme Drugs Market report?

Ans: The Applications covered in the Therapeutic Enzyme Drugs Market report are Gaucher Disease, MPS Disease, Gastrointestinal Diseases, Others

What are the Type segmentation covered in the Therapeutic Enzyme Drugs Market report?

Ans: The Types covered in the Therapeutic Enzyme Drugs Market report are Injectable, Oral, Topical

Recommended Reports

Therapeutic Drugs

Disease Treatment

Therapeutic Market Analysis

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Therapeutic Enzyme Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Injectable

1.2.3 Oral

1.2.4 Topical

1.3 Market by Application

1.3.1 Global Therapeutic Enzyme Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Gaucher Disease

1.3.3 MPS Disease

1.3.4 Gastrointestinal Diseases

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Therapeutic Enzyme Drugs Market Perspective (2020-2031)

2.2 Global Therapeutic Enzyme Drugs Growth Trends by Region

2.2.1 Global Therapeutic Enzyme Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Therapeutic Enzyme Drugs Historic Market Size by Region (2020-2025)

2.2.3 Therapeutic Enzyme Drugs Forecasted Market Size by Region (2026-2031)

2.3 Therapeutic Enzyme Drugs Market Dynamics

2.3.1 Therapeutic Enzyme Drugs Industry Trends

2.3.2 Therapeutic Enzyme Drugs Market Drivers

2.3.3 Therapeutic Enzyme Drugs Market Challenges

2.3.4 Therapeutic Enzyme Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Therapeutic Enzyme Drugs Players by Revenue

3.1.1 Global Top Therapeutic Enzyme Drugs Players by Revenue (2020-2025)

3.1.2 Global Therapeutic Enzyme Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Therapeutic Enzyme Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Therapeutic Enzyme Drugs Revenue

3.4 Global Therapeutic Enzyme Drugs Market Concentration Ratio

3.4.1 Global Therapeutic Enzyme Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Enzyme Drugs Revenue in 2024

3.5 Global Key Players of Therapeutic Enzyme Drugs Head office and Area Served

3.6 Global Key Players of Therapeutic Enzyme Drugs, Product and Application

3.7 Global Key Players of Therapeutic Enzyme Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Therapeutic Enzyme Drugs Breakdown Data by Type

4.1 Global Therapeutic Enzyme Drugs Historic Market Size by Type (2020-2025)

4.2 Global Therapeutic Enzyme Drugs Forecasted Market Size by Type (2026-2031)

5 Therapeutic Enzyme Drugs Breakdown Data by Application

5.1 Global Therapeutic Enzyme Drugs Historic Market Size by Application (2020-2025)

5.2 Global Therapeutic Enzyme Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Therapeutic Enzyme Drugs Market Size (2020-2031)

6.2 North America Therapeutic Enzyme Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Therapeutic Enzyme Drugs Market Size by Country (2020-2025)

6.4 North America Therapeutic Enzyme Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Therapeutic Enzyme Drugs Market Size (2020-2031)

7.2 Europe Therapeutic Enzyme Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Therapeutic Enzyme Drugs Market Size by Country (2020-2025)

7.4 Europe Therapeutic Enzyme Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Therapeutic Enzyme Drugs Market Size (2020-2031)

8.2 Asia-Pacific Therapeutic Enzyme Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Therapeutic Enzyme Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Therapeutic Enzyme Drugs Market Size (2020-2031)

9.2 Latin America Therapeutic Enzyme Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Therapeutic Enzyme Drugs Market Size by Country (2020-2025)

9.4 Latin America Therapeutic Enzyme Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Therapeutic Enzyme Drugs Market Size (2020-2031)

10.2 Middle East & Africa Therapeutic Enzyme Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Therapeutic Enzyme Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Therapeutic Enzyme Drugs Introduction

11.1.4 Sanofi Revenue in Therapeutic Enzyme Drugs Business (2020-2025)

11.1.5 Sanofi Recent Development

11.2 BioMarin

11.2.1 BioMarin Company Details

11.2.2 BioMarin Business Overview

11.2.3 BioMarin Therapeutic Enzyme Drugs Introduction

11.2.4 BioMarin Revenue in Therapeutic Enzyme Drugs Business (2020-2025)

11.2.5 BioMarin Recent Development

11.3 AbbVie

11.3.1 AbbVie Company Details

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Therapeutic Enzyme Drugs Introduction

11.3.4 AbbVie Revenue in Therapeutic Enzyme Drugs Business (2020-2025)

11.3.5 AbbVie Recent Development

11.4 Shire

11.4.1 Shire Company Details

11.4.2 Shire Business Overview

11.4.3 Shire Therapeutic Enzyme Drugs Introduction

11.4.4 Shire Revenue in Therapeutic Enzyme Drugs Business (2020-2025)

11.4.5 Shire Recent Development

11.5 Alexion

11.5.1 Alexion Company Details

11.5.2 Alexion Business Overview

11.5.3 Alexion Therapeutic Enzyme Drugs Introduction

11.5.4 Alexion Revenue in Therapeutic Enzyme Drugs Business (2020-2025)

11.5.5 Alexion Recent Development

11.6 Horizon Pharma

11.6.1 Horizon Pharma Company Details

11.6.2 Horizon Pharma Business Overview

11.6.3 Horizon Pharma Therapeutic Enzyme Drugs Introduction

11.6.4 Horizon Pharma Revenue in Therapeutic Enzyme Drugs Business (2020-2025)

11.6.5 Horizon Pharma Recent Development

11.7 Allergan

11.7.1 Allergan Company Details

11.7.2 Allergan Business Overview

11.7.3 Allergan Therapeutic Enzyme Drugs Introduction

11.7.4 Allergan Revenue in Therapeutic Enzyme Drugs Business (2020-2025)

11.7.5 Allergan Recent Development

11.8 Johnson & Johnson

11.8.1 Johnson & Johnson Company Details

11.8.2 Johnson & Johnson Business Overview

11.8.3 Johnson & Johnson Therapeutic Enzyme Drugs Introduction

11.8.4 Johnson & Johnson Revenue in Therapeutic Enzyme Drugs Business (2020-2025)

11.8.5 Johnson & Johnson Recent Development

11.9 Recordati Rare Diseases

11.9.1 Recordati Rare Diseases Company Details

11.9.2 Recordati Rare Diseases Business Overview

11.9.3 Recordati Rare Diseases Therapeutic Enzyme Drugs Introduction

11.9.4 Recordati Rare Diseases Revenue in Therapeutic Enzyme Drugs Business (2020-2025)

11.9.5 Recordati Rare Diseases Recent Development

11.10 Pfizer

11.10.1 Pfizer Company Details

11.10.2 Pfizer Business Overview

11.10.3 Pfizer Therapeutic Enzyme Drugs Introduction

11.10.4 Pfizer Revenue in Therapeutic Enzyme Drugs Business (2020-2025)

11.10.5 Pfizer Recent Development

11.11 Vivus

11.11.1 Vivus Company Details

11.11.2 Vivus Business Overview

11.11.3 Vivus Therapeutic Enzyme Drugs Introduction

11.11.4 Vivus Revenue in Therapeutic Enzyme Drugs Business (2020-2025)

11.11.5 Vivus Recent Development

11.12 Digestive Care

11.12.1 Digestive Care Company Details

11.12.2 Digestive Care Business Overview

11.12.3 Digestive Care Therapeutic Enzyme Drugs Introduction

11.12.4 Digestive Care Revenue in Therapeutic Enzyme Drugs Business (2020-2025)

11.12.5 Digestive Care Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AbbVie

Shire Plc

Alexion

Horizon Pharma

Allergan plc

Johnson & Johnson

Recordati Rare Diseases

Pfizer Inc

VIVUS

Digestive Care

BioMarin

Sanofi

List of Tables

Table 1. Global Therapeutic Enzyme Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Injectable

Table 3. Key Players of Oral

Table 4. Key Players of Topical

Table 5. Global Therapeutic Enzyme Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Therapeutic Enzyme Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Therapeutic Enzyme Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Therapeutic Enzyme Drugs Market Share by Region (2020-2025)

Table 9. Global Therapeutic Enzyme Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Therapeutic Enzyme Drugs Market Share by Region (2026-2031)

Table 11. Therapeutic Enzyme Drugs Market Trends

Table 12. Therapeutic Enzyme Drugs Market Drivers

Table 13. Therapeutic Enzyme Drugs Market Challenges

Table 14. Therapeutic Enzyme Drugs Market Restraints

Table 15. Global Therapeutic Enzyme Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Therapeutic Enzyme Drugs Market Share by Players (2020-2025)

Table 17. Global Top Therapeutic Enzyme Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Enzyme Drugs as of 2024)

Table 18. Ranking of Global Top Therapeutic Enzyme Drugs Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Therapeutic Enzyme Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Therapeutic Enzyme Drugs, Headquarters and Area Served

Table 21. Global Key Players of Therapeutic Enzyme Drugs, Product and Application

Table 22. Global Key Players of Therapeutic Enzyme Drugs, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Therapeutic Enzyme Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Therapeutic Enzyme Drugs Revenue Market Share by Type (2020-2025)

Table 26. Global Therapeutic Enzyme Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Therapeutic Enzyme Drugs Revenue Market Share by Type (2026-2031)

Table 28. Global Therapeutic Enzyme Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Therapeutic Enzyme Drugs Revenue Market Share by Application (2020-2025)

Table 30. Global Therapeutic Enzyme Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Therapeutic Enzyme Drugs Revenue Market Share by Application (2026-2031)

Table 32. North America Therapeutic Enzyme Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Therapeutic Enzyme Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Therapeutic Enzyme Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Therapeutic Enzyme Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Therapeutic Enzyme Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Therapeutic Enzyme Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Therapeutic Enzyme Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Therapeutic Enzyme Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Therapeutic Enzyme Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Therapeutic Enzyme Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Therapeutic Enzyme Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Therapeutic Enzyme Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Therapeutic Enzyme Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Therapeutic Enzyme Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Therapeutic Enzyme Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 47. Sanofi Company Details

Table 48. Sanofi Business Overview

Table 49. Sanofi Therapeutic Enzyme Drugs Product

Table 50. Sanofi Revenue in Therapeutic Enzyme Drugs Business (2020-2025) & (US$ Million)

Table 51. Sanofi Recent Development

Table 52. BioMarin Company Details

Table 53. BioMarin Business Overview

Table 54. BioMarin Therapeutic Enzyme Drugs Product

Table 55. BioMarin Revenue in Therapeutic Enzyme Drugs Business (2020-2025) & (US$ Million)

Table 56. BioMarin Recent Development

Table 57. AbbVie Company Details

Table 58. AbbVie Business Overview

Table 59. AbbVie Therapeutic Enzyme Drugs Product

Table 60. AbbVie Revenue in Therapeutic Enzyme Drugs Business (2020-2025) & (US$ Million)

Table 61. AbbVie Recent Development

Table 62. Shire Company Details

Table 63. Shire Business Overview

Table 64. Shire Therapeutic Enzyme Drugs Product

Table 65. Shire Revenue in Therapeutic Enzyme Drugs Business (2020-2025) & (US$ Million)

Table 66. Shire Recent Development

Table 67. Alexion Company Details

Table 68. Alexion Business Overview

Table 69. Alexion Therapeutic Enzyme Drugs Product

Table 70. Alexion Revenue in Therapeutic Enzyme Drugs Business (2020-2025) & (US$ Million)

Table 71. Alexion Recent Development

Table 72. Horizon Pharma Company Details

Table 73. Horizon Pharma Business Overview

Table 74. Horizon Pharma Therapeutic Enzyme Drugs Product

Table 75. Horizon Pharma Revenue in Therapeutic Enzyme Drugs Business (2020-2025) & (US$ Million)

Table 76. Horizon Pharma Recent Development

Table 77. Allergan Company Details

Table 78. Allergan Business Overview

Table 79. Allergan Therapeutic Enzyme Drugs Product

Table 80. Allergan Revenue in Therapeutic Enzyme Drugs Business (2020-2025) & (US$ Million)

Table 81. Allergan Recent Development

Table 82. Johnson & Johnson Company Details

Table 83. Johnson & Johnson Business Overview

Table 84. Johnson & Johnson Therapeutic Enzyme Drugs Product

Table 85. Johnson & Johnson Revenue in Therapeutic Enzyme Drugs Business (2020-2025) & (US$ Million)

Table 86. Johnson & Johnson Recent Development

Table 87. Recordati Rare Diseases Company Details

Table 88. Recordati Rare Diseases Business Overview

Table 89. Recordati Rare Diseases Therapeutic Enzyme Drugs Product

Table 90. Recordati Rare Diseases Revenue in Therapeutic Enzyme Drugs Business (2020-2025) & (US$ Million)

Table 91. Recordati Rare Diseases Recent Development

Table 92. Pfizer Company Details

Table 93. Pfizer Business Overview

Table 94. Pfizer Therapeutic Enzyme Drugs Product

Table 95. Pfizer Revenue in Therapeutic Enzyme Drugs Business (2020-2025) & (US$ Million)

Table 96. Pfizer Recent Development

Table 97. Vivus Company Details

Table 98. Vivus Business Overview

Table 99. Vivus Therapeutic Enzyme Drugs Product

Table 100. Vivus Revenue in Therapeutic Enzyme Drugs Business (2020-2025) & (US$ Million)

Table 101. Vivus Recent Development

Table 102. Digestive Care Company Details

Table 103. Digestive Care Business Overview

Table 104. Digestive Care Therapeutic Enzyme Drugs Product

Table 105. Digestive Care Revenue in Therapeutic Enzyme Drugs Business (2020-2025) & (US$ Million)

Table 106. Digestive Care Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

Table 110. Authors List of This Report

List of Figures

Figure 1. Therapeutic Enzyme Drugs Picture

Figure 2. Global Therapeutic Enzyme Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Therapeutic Enzyme Drugs Market Share by Type: 2024 VS 2031

Figure 4. Injectable Features

Figure 5. Oral Features

Figure 6. Topical Features

Figure 7. Global Therapeutic Enzyme Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Therapeutic Enzyme Drugs Market Share by Application: 2024 VS 2031

Figure 9. Gaucher Disease Case Studies

Figure 10. MPS Disease Case Studies

Figure 11. Gastrointestinal Diseases Case Studies

Figure 12. Others Case Studies

Figure 13. Therapeutic Enzyme Drugs Report Years Considered

Figure 14. Global Therapeutic Enzyme Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Therapeutic Enzyme Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Therapeutic Enzyme Drugs Market Share by Region: 2024 VS 2031

Figure 17. Global Therapeutic Enzyme Drugs Market Share by Players in 2024

Figure 18. Global Top Therapeutic Enzyme Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Enzyme Drugs as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Therapeutic Enzyme Drugs Revenue in 2024

Figure 20. North America Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Therapeutic Enzyme Drugs Market Share by Country (2020-2031)

Figure 22. United States Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Therapeutic Enzyme Drugs Market Share by Country (2020-2031)

Figure 26. Germany Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Therapeutic Enzyme Drugs Market Share by Region (2020-2031)

Figure 34. China Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Therapeutic Enzyme Drugs Market Share by Country (2020-2031)

Figure 42. Mexico Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Therapeutic Enzyme Drugs Market Share by Country (2020-2031)

Figure 46. Turkey Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Therapeutic Enzyme Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Sanofi Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2020-2025)

Figure 50. BioMarin Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2020-2025)

Figure 51. AbbVie Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2020-2025)

Figure 52. Shire Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2020-2025)

Figure 53. Alexion Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2020-2025)

Figure 54. Horizon Pharma Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2020-2025)

Figure 55. Allergan Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2020-2025)

Figure 56. Johnson & Johnson Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2020-2025)

Figure 57. Recordati Rare Diseases Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2020-2025)

Figure 58. Pfizer Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2020-2025)

Figure 59. Vivus Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2020-2025)

Figure 60. Digestive Care Revenue Growth Rate in Therapeutic Enzyme Drugs Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Drug Discovery Enzymes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Medical Enzyme Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Enzymes for Diagnostic Drugs Market Research Report 2025

Enzymes for Research and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Therapeutic Recombinant Protein Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Enzyme Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Catalysts Enzymes Market Research Report 2025

In vitro Diagnostics Enzymes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Healthcare Specialty Enzymes Market

Global Hydrolase Enzymes Market Research Report 2025

Molecular Diagnostic Raw Enzymes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Enzyme Product Market Research Report 2025

Global Enzyme Profiling Service Market Research Report 2025

Global NASH Therapeutic Drugs Market Insights Forecast to 2030

Global Enzymes For Agriculture Market Research Report 2025

Protease Enzymes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Enzymes For Bioenergy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liver Diseases Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Microbiome Therapeutic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions